BKBG
IMMU

BHF Kleinwort Benson Group’s Immunomedics Inc IMMU Stock Holding History

BHF Kleinwort Benson Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-13,000
Closed -$34K – 584
2014
Q2 		$34K Sell
13,000
-14,000
-52% -$51.4K ﹤0.01% 491
2014
Q1 		$84K Buy
+27,000
New +$134K ﹤0.01% 463

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BHF Kleinwort Benson Group's IMMU Position: Q3 2014 in Review

BHF Kleinwort Benson Group sold out of Immunomedics Inc (IMMU) in Q3 2014, closing a stake of 13,000 shares — an estimated $34K sold.

BHF Kleinwort Benson Group first reported a position in IMMU in Q1 2014 and held it in 2 quarters. The position peaked at $84K in Q1 2014. 81 funds tracked by Wall St. Rank hold IMMU as of Q3 2014.

  • BHF Kleinwort Benson Group reported no remaining Immunomedics Inc position as of Q3 2014 after selling out during the quarter.
  • BHF Kleinwort Benson Group sold 13,000 Immunomedics Inc shares in Q3 2014, an estimated $34K.
  • BHF Kleinwort Benson Group first reported a position in Immunomedics Inc in Q1 2014 and held it in 2 quarters.
  • BHF Kleinwort Benson Group's Immunomedics Inc position peaked at $84K in Q1 2014.
  • 81 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2014.

Based on BHF Kleinwort Benson Group's 13F filing for Q3 2014, filed 20 Feb 2015.